American Society of Hirudotherapy

Utilising the Flap Vein of a Pedicled TRAM Flap for LYMPHA: A Case Report

Research article published in World journal of plastic surgery (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportClinical TrialsZhang et al. · World journal of plastic surgery, 2025

Abstract

Upper extremity lymphedema is a common and disabling complication of breast cancer treatment, especially following axillary lymph node dissection (ALND). Its risk may be reduced with the Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) procedure, which involves anastomosis of one or more upper limb lymphatic channels to a recipient vein, usually a branch of the axillary vein within the axilla. However, these branches may sometimes be difficult to identify or even not be in suitable condition, especially if extensive electrocautery was used during ALND. If autologous breast reconstruction is performed simultaneously, a flap vein may serve as a reliable recipient vein for anastomosis. We describe a simple and potentially useful technique of utilizing the flap vein (deep inferior epigastric vein) of a pedicled transverse rectus abdominis myocutaneous flap, as a recipient vein for the lymphaticovenular anastomosis in LYMPHA.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This case report described a surgical technique that uses the flap vein (deep inferior epigastric vein) of a pedicled TRAM flap as the recipient vein for lymphaticovenular anastomosis during the LYMPHA procedure, offered as a way to reduce upper-limb lymphedema risk after axillary node dissection when usual axillary vein branches are unsuitable. For ASH it is tangential context within reconstructive and microsurgical practice, the broad clinical territory where medicinal leeches are sometimes used for venous-congested flaps; it does not address leech therapy in any way. The abstract contains no reference to hirudotherapy or any leech secretome component, and as a single-patient technical case report it carries the lowest tier of clinical evidence, illustrating feasibility of a method rather than demonstrating an outcome.

Citation

Utilising the Flap Vein of a Pedicled TRAM Flap for LYMPHA: A Case Report.

Zhang et al. · World journal of plastic surgery, 2025

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.